Receipt of notification from a shareholder under Article 69 of the Act on Public Offering
Current report 4/2017
The Management Board of Medicalgorithmics S.A. with its registered office in Warsaw (“Company”) hereby announces that on 4 April 2017 it received a notification pursuant to Article 69(1)(2) in conjunction with Article 87(1)(2)(a) of the Act of 29 July 2005 on public offering and conditions for the introduction of financial instruments to organised trading system and on public companies (consolidated text: Journal of Laws of 2016, item 1639) from the shareholder Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych S.A. acting:
- on its own behalf as an entity authorized to manage portfolios of investment funds and as a body authorized to represent investment funds;
- for and on behalf of Aviva Investors Fundusz Inwestycyjny Otwarty and Aviva Investors Specjalistyczny Fundusz Inwestycyjny Otwarty (“Funds”);
regarding the Funds exceeding the threshold of 5% of total voting rights at the Company as a result of a purchase of the Company’s shares on 31 March 2017 (“Transaction”).
As a result of the Transaction, the Funds hold 200,267 shares of the Company representing 5.55% of the Company’s share capital and carrying 200,267 votes, constituting 5.55% of the total number of votes at the Company’s general meeting.
Before the Transaction, the Funds held 175,195 shares of the Company representing 4.86% of the Company’s share capital and carrying 175,195 votes, constituting 4.86% of the total number of votes at the Company’s general meeting.
The Funds do not have any subsidiaries which hold shares or rights to shares of the Company.